loading...| Preferred Name |
Mitomycin |
|
| Synonyms |
Mitomycin-C Mitomycin-X Mitomycine C [1aS-(1a alpha,8beta,8a alpha,8b alpha)]-6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione Mitomycin C MITOMYCIN C (1aS,8S,8aR,8bS)-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione Ametycine Jelmyto MITO MITO-C MITOMYCIN Mito-C Mito-Medac Mitocin Mitocin-C Mitolem Mitomycin Mitosol Mitozytrex Mutamycin Mutamycine NCI-C04706 |
|
| Definitions |
A methylazirinopyrroloindoledione antineoplastic antibiotic isolated from the bacterium Streptomyces caespitosus and other Streptomyces bacterial species. Bioreduced mitomycin C generates oxygen radicals, alkylates DNA, and produces interstrand DNA cross-links, thereby inhibiting DNA synthesis. Preferentially toxic to hypoxic cells, mitomycin C also inhibits RNA and protein synthesis at high concentrations. (NCI04) |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1820 |
|
| Accepted_Therapeutic_Use_For |
Gastric Carcinoma Pancreatic Adenocarcinoma |
|
| CAS_Registry |
50-07-7 |
|
| CHEBI_ID |
CHEBI:27504 |
|
| Chemical_Formula |
C15H18N4O5 |
|
| code |
C1820 |
|
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C201600 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C128784 |
|
| Contributing_Source |
CTRP FDA GDC HemOnc |
|
| DEFINITION |
A methylazirinopyrroloindoledione antineoplastic antibiotic isolated from the bacterium Streptomyces caespitosus and other Streptomyces bacterial species. Bioreduced mitomycin C generates oxygen radicals, alkylates DNA, and produces interstrand DNA cross-links, thereby inhibiting DNA synthesis. Preferentially toxic to hypoxic cells, mitomycin C also inhibits RNA and protein synthesis at high concentrations. (NCI04) |
|
| Display_Name |
Mitomycin |
|
| FDA_UNII_Code |
50SG953SK6 |
|
| FULL_SYN |
Mitomycin-C Mitomycin-X Mitomycine C [1aS-(1a alpha,8beta,8a alpha,8b alpha)]-6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione Mitomycin C MITOMYCIN C (1aS,8S,8aR,8bS)-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione Ametycine Jelmyto MITO MITO-C MITOMYCIN Mito-C Mito-Medac Mitocin Mitocin-C Mitolem Mitomycin Mitosol Mitozytrex Mutamycin Mutamycine NCI-C04706 |
|
| Is_Value_For_GDC_Property | ||
| label |
Mitomycin |
|
| Legacy Concept Name |
Mitomycin_C |
|
| Maps_To |
Mitomycin |
|
| NCI_Drug_Dictionary_ID |
42674 |
|
| NSC Number |
26980 |
|
| PDQ_Closed_Trial_Search_ID |
42674 |
|
| PDQ_Open_Trial_Search_ID |
42674 |
|
| Preferred_Name |
Mitomycin |
|
| prefixIRI |
Thesaurus:C1820 |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance Antibiotic |
|
| UMLS_CUI |
C0002475 |
|
| subClassOf |